Sign in
4

Changes in Ownership

PROVECTUS BIOPHARMACEUTICALS, INC. Filed Acc 0001493152-24-032463

10% owner acquired 264,314 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Morris Jeffrey Allen 10% owner 2024-08-12 Conversion +264,314 $2.86 $756,467 4,260,061 D: show line 1 in the form
Loading xslF345X05/ownership.xml…